Search Results
10
Everything
Search Filters
Tag
Medical Research
Aclarion Announces Reverse Stock Split
March 26, 2025 07:00 ET
|
Aclarion, Inc.
Aclarion Announces Reverse Stock Split
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
March 24, 2025 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
March 18, 2025 16:05 ET
|
OncoCyte Corporation
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
March 17, 2025 08:00 ET
|
Halberd Corp.
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
Aclarion Provides Shareholder Update
March 13, 2025 09:25 ET
|
Aclarion, Inc.
Aclarion Files Shareholder Update
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
March 06, 2025 09:35 ET
|
Aclarion, Inc.
Aclarion Announces Expansion Plans with RadNet Affiliates
in New York and New Jersey
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
February 28, 2025 16:01 ET
|
Aclarion, Inc.
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
February 20, 2025 06:00 ET
|
Aclarion, Inc.
Aclarion to Showcase Groundbreaking NOCISCAN Technology
at the 2025 Spine Summit
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
February 11, 2025 07:58 ET
|
Aclarion, Inc.
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing
Oncocyte Prices $29.1 Million Equity Offering
February 10, 2025 08:30 ET
|
OncoCyte Corporation
Oncocyte Prices $29.1 Million Equity Offering